Literature DB >> 22926622

Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania.

Rodrigo Machado-Vieira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22926622     DOI： 10.1097/JCP.0b013e318268391d

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  9 in total

1.  Preventive Effect of Cecropia pachystachya Against Ketamine-Induced Manic Behavior and Oxidative Stress in Rats.

Authors:  Marta Gazal; Fernanda N Kaufmann; Bruna A Acosta; Pathise Souto Oliveira; Matheus R Valente; Caroline Flach Ortmann; Régis Sturbelle; Claiton L Lencina; Francieli M Stefanello; Manuella P Kaster; Flávio Henrique Reginatto; Gabriele Ghisleni
Journal:  Neurochem Res       Date:  2015-05-22       Impact factor: 3.996

Review 2.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

Review 3.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

4.  NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDER.

Authors:  Daniel C Mathews; Erica M Richards; Mark J Niciu; Dawn F Ionescu; Joseph J Rasimas; Carlos A Zarate
Journal:  Transl Neurosci       Date:  2013-06       Impact factor: 1.757

5.  Patients With Drug-Naive Bipolar Disorder in Remission After 8 Weeks of Treatment Had Decreased Serum Uric Acid Concentrations.

Authors:  Jing-Xu Chen; Li-Gang Zhang; Ke-Zhi Liu; Hong-Mei Chen; Shuang-Jiang Zhou; Ning Wang; Yun-Long Tan; Shao-Li Wang; Alison Jones; Fu-De Yang; Xu-Feng Huang
Journal:  Front Psychiatry       Date:  2019-10-31       Impact factor: 4.157

Review 6.  The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder.

Authors:  Maria Carolina Bittencourt Gonçalves; Roberta Andrejew; Carolina Gubert
Journal:  CNS Drugs       Date:  2022-07-13       Impact factor: 6.497

7.  The prevalence and associated clinical correlates of hyperuricemia in patients with bipolar disorder.

Authors:  Shuyun Li; Xiaobing Lu; Xiaodong Chen; Zebin Huang; Hui Zhou; Zezhi Li; Yuping Ning
Journal:  Front Neurosci       Date:  2022-09-16       Impact factor: 5.152

8.  Increased Serum C3 and Decreased UA in Patients of Bipolar Disorder in Chinese Han Population.

Authors:  Xiudeng Yang; Huai Tao; Ledong Xiao; Cunyan Li; Yamei Tang; Yong Liu
Journal:  Front Psychiatry       Date:  2018-08-21       Impact factor: 4.157

9.  Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case-control study.

Authors:  Zhe Lu; Yingtan Wang; Guanglei Xun
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.